Cellectis (CLLS) Research & Development (2016 - 2023)
Historic Research & Development for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to -$19.1 million.
- Cellectis' Research & Development rose 1997.73% to -$19.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$84.1 million, marking a year-over-year increase of 2034.03%. This contributed to the annual value of -$97.5 million for FY2022, which is 1725.98% up from last year.
- Per Cellectis' latest filing, its Research & Development stood at -$19.1 million for Q3 2023, which was up 1997.73% from -$22.2 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Research & Development ranged from a high of $23.4 million in Q4 2020 and a low of -$34.3 million during Q3 2021
- Its 5-year average for Research & Development is -$22.0 million, with a median of -$22.9 million in 2020.
- Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 17714.76% in 2020, then plummeted by 22624.49% in 2021.
- Quarter analysis of 5 years shows Cellectis' Research & Development stood at -$30.3 million in 2019, then soared by 177.15% to $23.4 million in 2020, then plummeted by 226.24% to -$29.5 million in 2021, then rose by 27.43% to -$21.4 million in 2022, then grew by 11.0% to -$19.1 million in 2023.
- Its Research & Development was -$19.1 million in Q3 2023, compared to -$22.2 million in Q2 2023 and -$21.4 million in Q1 2023.